Back to Results
Ilana M. Schlam, MD
Accepting New Patients
Meet Ilana M. Schlam, MD
Title(s)
Hematologist/Oncologist
Department + Services
Medicine, Hematology/Oncology
Clinical Focus Areas
Breast medical oncology
Research Focus Areas
Breast cancer, immunotherapy
Seeing Patients In
Boston, 617-636-6227
Request Appointment
Programs + Specialties |
|
Training + Education |
Anahuac University, Mexico City; Residency and Chief Resident: Internal Medicine, Jewish Hospital, Mercy Health;
Fellowship and Chief Fellow: Hematology/Oncology, Georgetown-Washington University Hospitals
|
Board Certifications |
Internal Medicine |
NPI # |
1760862973 |
Gender |
Female |
Language(s) |
Spanish, Hebrew |
Accepted Insurances |
View Accepted Insurances at Tufts Medical Center
|
Tufts Medical Center
South Building, 8th Floor
800 Washington Street
Boston, MA 02111
Phone #: 617-636-6227
Fax #: 617-636-8538
|
2021 Conquer Cancer Foundation-ASCO Young Investigator Award
2020-2021 FDA-AACR Oncology Educational Fellowship
2020 ASCO/AACR Workshop in Methods in Clinical Cancer Research, Vail (Workshop cancelled)
2020 ASH Medical Educators Institute Award
2020, Top abstract award – Advancing the Cardiovascular Care of the Oncology Patient, American College of Cardiology
2018, Research Scholar Award, Jewish Hospital—Mercy Health
2018, Young Achiever, American College of Physicians
Schlam I, Lee A, Li S, Sheikh F, Zaghlol R, Basyal B, Gallagher C, Molina E, Mahr C, Cheng R, Barac A. Left Ventricular Assist Devices in Patients with Active Malignancies. JAAC Cardio- Oncology. 2021 June. 3 (2) 305–315
Schlam I, Swain S. HER2-positive breast cancer and tyrosine kinase inhibitors: The time is now. Npj Breast. 2021 May 20;7(1):56. doi: 10.1038/s41523-021-00265-1. PMID: 34016991
Schlam I, Tolaney S. Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases? Oncotarget. 2021 Apr 27;12(9):873-875. doi: 10.18632/oncotarget.27904. PMID: 33953840
Lynce F, Schlam I, Geng X, Peshkin B, Friedman S, Dutil J, Nahleh Z, Campos C, Ricker C, Rodriguez P, Denduluri N, Ahn J, Isaacs C, Graves K. BRCA1/2 mutations and risk reducing bilateral salpingo-oophorectomy among Latinas: the UPTAKE study. Journal of Genetic Counseling. 2020 Oct 3. doi: 10.1002/jgc4.1322 PMID: 33010199
Schlam I, Sewaralthahab S, Peravali M, Chou C, Gilligan T, Veytsman I, Shenoy A. Improving feedback for hematologists and oncologists in training. 2021 American Society of Clinical Oncology Annual Meeting. Virtual meeting. June 2021
Schlam I, Church SE, Chaldekas K, Harris BT, Hudson BM, White AM, Swain S. Digital spatial profiling in HER2 positive breast cancer: The road to precision medicine. 2020 American Association for Cancer Research Annual Meeting. Virtual meeting. April 2021
Schlam I, Smith M, Chang I, Dilawari A, Peer C, Sissung T, Tan M, Figg D, Swain S. Racial disparities in CYP3A variants in the metabolism of ribociclib in breast cancer patients. 2020 San Antonio Breast Cancer Symposium. Virtual meeting. December 2020.
Schlam I, Campos C, Duron Y, Sampayo I, Graves K. Effect of linguistic acculturation on self-efficacy and anxiety in caregivers of Latina breast cancer survivors. 2020 American Society of Clinical Oncology Annual Meeting. Virtual meeting. June 2020. J Clin Oncol 38: 2020 (suppl; abstr 12121)
American Society of Clinical Oncology
American Society of Hematology
European Society for Medical Oncology
American Association for Cancer Research